Budgeting and research help parents save on back to school shopping.
Precision medicine found the right drug for the right patient, helping one UAB prostate cancer patient make a remarkable recovery.
UAB will launch a new Bachelor of Science degree program in bioinformatics this fall.
UAB’s first Addiction Recovery symposium features thought leaders and inspirational stories.
Recovery from an eating disorder has helped one former Blazer athlete solidify her career path and has her determined to help others.
The five-year funding award will support the Southern All of Us Network, part of the All of Us Research Program, a nationwide research program to transform how research is conducted to advance individualized prevention, treatment and care for people of all backgrounds.
A student-led startup company and product of the new UAB Commercialization Accelerator is profitable and moving into Innovation Depot.
When you struggle with weight issues, it is easy to feel overwhelmed by your weight loss options and dismayed by setbacks.
Local companies are getting a boost from students in UAB’s Academic Small Business Alliance. The program matches students seeking career experience with companies needing additional brainpower to grow.
This week, a common blood pressure drug is revealed to be an effective therapy for Type I diabetes, a team from NSF is helping faculty and staff better understand how to commercialize their technology and work on the new intramural fields is nearly complete.
Kindergarten teacher Heather Simpson has been awarded the Presidential Award for Excellence in Mathematics and Science Teaching.
An assistant professor in UAB’s Department of Urology receives K08 grant.
Nursing students spend a semester helping provide basic health care to adults who are mentally or physically disabled and attend the Wylam Adult Day Health Care Center in Birmingham.
The mechanism the tuberculosis pathogen uses in its escape suggests possible therapies to improve patient outcomes.
Multivitamins and mineral supplements do not prevent heart attacks, strokes or cardiovascular death.
A gene called TXNIP was the answer, and it led to a drug called verapamil and a successful diabetes trial.
Significant novel findings published by UAB researchers established verapamil as a successful therapeutic approach to target loss of beta cell function caused by Type 1 diabetes.

Biomedical scientists and engineers can participate in a nationwide program that helps take their discoveries from the research lab to the clinical setting.

This week is all about a promising new viral immunotherapy for brain tumors in children. Plus, 18 new electric vehicle-charging stations have come to campus, and UAB's EITD contract with NASA has doubled to $50 million. See it online. All in one video.
Back to Top